KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2017 - 2025)

Sarepta Therapeutics has reported Asset Utilization Ratio over the past 13 years, most recently at 0.64 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.64 for Q4 2025, up 27.74% from a year ago — trailing twelve months through Dec 2025 was 0.64 (up 27.74% YoY), and the annual figure for FY2025 was 0.6, up 14.23%.
  • Asset Utilization Ratio for Q4 2025 was 0.64 at Sarepta Therapeutics, down from 0.67 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for SRPT hit a ceiling of 0.69 in Q2 2025 and a floor of 0.15 in Q3 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.35 (2023), compared with a mean of 0.4.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 35.37% in 2022 and later soared 144.1% in 2023.
  • Sarepta Therapeutics' Asset Utilization Ratio stood at 0.24 in 2021, then surged by 36.01% to 0.33 in 2022, then surged by 36.7% to 0.45 in 2023, then rose by 11.97% to 0.5 in 2024, then grew by 27.74% to 0.64 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.64 (Q4 2025), 0.67 (Q3 2025), and 0.69 (Q2 2025) per Business Quant data.